Corporates hit Click in $19m round
Drug developers Sanofi and Hikma both contributed to a funding round for health management app developer Click Therapeutics to bring its total financing to more than $26m.
Corporates see Sense for $18m series B
Household energy monitor developer Sense has expanded its overall funding to almost $39m in a round backed by Schneider Electric and existing investors Shell and iRobot.
Vector successfully angles for $70m series B
Kanematsu-backed microsatellite launch services provider Vector has collected $70m in a series B round that brought its total funding to more than $100m.
Vacasa books into $64m round
Vacasa has added $64m in an Assurant-backed round that will help the holiday property manager pursue further domestic and international expansion.
TP Therapeutics tops series C with $80m
The cancer therapy developer has raised $80m in a mezzanine round that came almost 18 months after its series C, with Lilly Asia Ventures and SR One backing both rounds.
Revolution acquires Warp Drive to accelerate progress
Warp Drive Bio, the genomic medicine developer co-founded by Sanofi, has agreed to an all-share acquisition by Revolution Medicines.
CuraSen lures Johnson & Johnson to series A
Johnson & Johnson Innovation – JJDC was among the investors in CuraSen Therapeutics' $54.5m series A round, which was led by New Leaf Venture Partners.
Microsoft returns to WhiteSource for $35m round
Open-source cybersecurity software provider WhiteSource has raised cash in a series C round led by Susquehanna Growth Equity that included Microsoft's M12 unit.

News Continued

Tastemade cooks up $35m in funding
Amazon and existing backer Comcast both invested in a round that boosted lifestyle media platform Tastemade's total funding to $115m.
Corporate venturing deal net: 15-19 October 2018
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Alibaba makes a $288m date with 1919
Alibaba is set to invest $288m in the alcoholic drinks retailer at a time when consumer demand for wine and spirits is rapidly growing in China.
Holatek raises $86m from successful series D projection
Smart projector and TV manufacturer Holatek has attracted $86.5m in series D funding from a consortium led by Alibaba that featured the newly unveiled 36Kr Fund.
SI-Bone burrows into public markets with $108m IPO
The Novo-backed surgical implant provider floated at the top of its range and increased the number of shares in the offering.
Corporates drive Momenta to $1bn valuation
Tencent and existing backer Nio Capital both invested as autonomous driving software developer Momenta took its overall funding to $200m.

Editor's Picks

Chehaoduo shifts into next round with $162m
Seven months after raising $818m in a series C round led by Tencent, Chehaoduo has added $162m in series C-plus funding alongside a $430m commitment from the city of Kunshan.
Instacart bags up $600m
The grocery delivery service, which counts Amazon, American Express and Comcast as investors, has increased its valuation 75% to $7.6bn in just six months.
Allogene rallies to $324m IPO
The Pfizer and Gilead-backed immuno-oncology therapy developer, which had raised $300m in an April series A round, floated at the top of its range.
Snowflake packs in $450m
Capital One Growth Ventures returned to invest in the data warehousing software provider as part of a round that more than doubled its post-money valuation.
test reg


Not yet subscribed?

See your subscription offers here